These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 9797137

  • 1. Therapeutic efficacy of mouse-human chimeric anti-ganglioside GM2 monoclonal antibody against multiple organ micrometastases of human lung cancer in NK cell-depleted SCID mice.
    Hanibuchi M, Yano S, Nishioka Y, Yanagawa H, Kawano T, Sone S.
    Int J Cancer; 1998 Nov 09; 78(4):480-5. PubMed ID: 9797137
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Anti-ganglioside GM2 monoclonal antibody-dependent killing of human lung cancer cells by lymphocytes and monocytes.
    Hanibuchi M, Yano S, Nishioka Y, Yanagawa H, Sone S.
    Jpn J Cancer Res; 1996 May 09; 87(5):497-504. PubMed ID: 8641987
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Genetically engineered humanized anti-ganglioside GM2 antibody against multiple organ metastasis produced by GM2-expressing small-cell lung cancer cells.
    Yamada T, Bando H, Takeuchi S, Kita K, Li Q, Wang W, Akinaga S, Nishioka Y, Sone S, Yano S.
    Cancer Sci; 2011 Dec 09; 102(12):2157-63. PubMed ID: 21895875
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Humanized anti-ganglioside GM2 antibody is effective to induce antibody-dependent cell-mediated cytotoxicity in mononuclear cells from lung cancer patients.
    Parajuli P, Yanagawa H, Hanibuchi M, Takeuchi E, Miki T, Yano S, Sone S.
    Cancer Lett; 2001 Apr 26; 165(2):179-84. PubMed ID: 11275367
    [Abstract] [Full Text] [Related]

  • 10. Chimeric anti-ganglioside GM2 antibody with antitumor activity.
    Nakamura K, Koike M, Shitara K, Kuwana Y, Kiuragi K, Igarashi S, Hasegawa M, Hanai N.
    Cancer Res; 1994 Mar 15; 54(6):1511-6. PubMed ID: 8137257
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Dissection and optimization of immune effector functions of humanized anti-ganglioside GM2 monoclonal antibody.
    Nakamura K, Tanaka Y, Fujino I, Hirayama N, Shitara K, Hanai N.
    Mol Immunol; 2000 Dec 15; 37(17):1035-46. PubMed ID: 11399321
    [Abstract] [Full Text] [Related]

  • 18. Characterization of a proapoptotic antiganglioside GM2 monoclonal antibody and evaluation of its therapeutic effect on melanoma and small cell lung carcinoma xenografts.
    Retter MW, Johnson JC, Peckham DW, Bannink JE, Bangur CS, Dresser K, Cai F, Foy TM, Fanger NA, Fanger GR, Woda B, Rock KL.
    Cancer Res; 2005 Jul 15; 65(14):6425-34. PubMed ID: 16024647
    [Abstract] [Full Text] [Related]

  • 19. Recombinant antibodies against ganglioside expressed on tumor cells.
    Hanai N, Nakamura K, Shitara K.
    Cancer Chemother Pharmacol; 2000 Jul 15; 46 Suppl():S13-7. PubMed ID: 10950141
    [Abstract] [Full Text] [Related]

  • 20. Parathyroid hormone-related protein (PTHrP) is responsible for production of bone metastasis, but not visceral metastasis, by human small cell lung cancer SBC-5 cells in natural killer cell-depleted SCID mice.
    Miki T, Yano S, Hanibuchi M, Kanematsu T, Muguruma H, Sone S.
    Int J Cancer; 2004 Feb 10; 108(4):511-5. PubMed ID: 14696114
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.